Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse. 1990

H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
Department of Pharmacology and Toxicology, University of Oulu, Finland.

Polyclonal antibodies generated to four distinct mouse liver phenobarbital-inducible cytochrome P450 isoforms were used to analyse related forms in human liver. N-terminal sequence analysis and biochemical properties of the P450s used as antigens suggest that they belong to P450 subfamilies IIB (P450PBI), IA (P450PBII), IIC (P450PBIII) and IIA (P450Coh). In immunoblot analysis, anti-P450PBII detected a single protein presumed to be P450IA2 in all the human livers tested. No proteins corresponding with P450IA1 could be detected. Anti-PBIII and anti-P450Coh antibodies each detected one band (54 and 48 kDa, respectively) in the liver samples. No bands were revealed by anti-P450PBI antibody. Protein dot-immunobinding analysis showed that P450s immunodetectable by anti-P450PBII, anti-P450PBIII and anti-P450Coh antibodies are expressed in human liver (range 9 to 69 pmol P450/mg protein). In immunoinhibition experiments the activity of 7-ethoxyresorutin O-deethylase (EROD) was blocked up to 90% by the anti-P450PBII antibody. Aryl hydrocarbon hydroxylase (AHH) was inhibited only by anti-P450PBIII, and coumarin 7-hydroxylase (COH) only by anti-P450Coh antibody. Testosterone hydroxylations in positions 6 beta, 7 alpha, 15 alpha and 16 alpha were not affected significantly by any of the antibodies. These data suggest that the human liver P450IA2 is responsible for most of the elevated EROD activity, P450s in the IIC subfamily for constitutive AHH and P450s in the IIA subfamily for all of COH activity.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008811 Mice, Inbred DBA An inbred strain of mouse. Specific substrains are used in a variety of areas of BIOMEDICAL RESEARCH such as DBA/1J, which is used as a model for RHEUMATOID ARTHRITIS. Mice, DBA,Mouse, DBA,Mouse, Inbred DBA,DBA Mice,DBA Mice, Inbred,DBA Mouse,DBA Mouse, Inbred,Inbred DBA Mice,Inbred DBA Mouse
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D003577 Cytochrome P-450 Enzyme System A superfamily of hundreds of closely related HEMEPROTEINS found throughout the phylogenetic spectrum, from animals, plants, fungi, to bacteria. They include numerous complex monooxygenases (MIXED FUNCTION OXYGENASES). In animals, these P-450 enzymes serve two major functions: (1) biosynthesis of steroids, fatty acids, and bile acids; (2) metabolism of endogenous and a wide variety of exogenous substrates, such as toxins and drugs (BIOTRANSFORMATION). They are classified, according to their sequence similarities rather than functions, into CYP gene families (>40% homology) and subfamilies (>59% homology). For example, enzymes from the CYP1, CYP2, and CYP3 gene families are responsible for most drug metabolism. Cytochrome P-450,Cytochrome P-450 Enzyme,Cytochrome P-450-Dependent Monooxygenase,P-450 Enzyme,P450 Enzyme,CYP450 Family,CYP450 Superfamily,Cytochrome P-450 Enzymes,Cytochrome P-450 Families,Cytochrome P-450 Monooxygenase,Cytochrome P-450 Oxygenase,Cytochrome P-450 Superfamily,Cytochrome P450,Cytochrome P450 Superfamily,Cytochrome p450 Families,P-450 Enzymes,P450 Enzymes,Cytochrome P 450,Cytochrome P 450 Dependent Monooxygenase,Cytochrome P 450 Enzyme,Cytochrome P 450 Enzyme System,Cytochrome P 450 Enzymes,Cytochrome P 450 Families,Cytochrome P 450 Monooxygenase,Cytochrome P 450 Oxygenase,Cytochrome P 450 Superfamily,Enzyme, Cytochrome P-450,Enzyme, P-450,Enzyme, P450,Enzymes, Cytochrome P-450,Enzymes, P-450,Enzymes, P450,Monooxygenase, Cytochrome P-450,Monooxygenase, Cytochrome P-450-Dependent,P 450 Enzyme,P 450 Enzymes,P-450 Enzyme, Cytochrome,P-450 Enzymes, Cytochrome,Superfamily, CYP450,Superfamily, Cytochrome P-450,Superfamily, Cytochrome P450
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
February 1993, Biochemical pharmacology,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
August 1989, Archives of biochemistry and biophysics,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
May 1991, Archives of biochemistry and biophysics,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
June 1989, Archives of biochemistry and biophysics,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
February 1985, Gastroenterology,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
November 1982, FEBS letters,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
November 1991, Archives of biochemistry and biophysics,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
May 1992, Biochemical pharmacology,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
February 1984, Carcinogenesis,
H Raunio, and J Valtonen, and P Honkakoski, and M A Lang, and M Ståhlberg, and M A Kairaluoma, and A Rautio, and M Pasanen, and O Pelkonen
December 1995, Drug metabolism and disposition: the biological fate of chemicals,
Copied contents to your clipboard!